Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2022
Okus FZehra, Azizoglu ZBusra, Canatan H, Eken A. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo. Int Immunopharmacol. 2022;107:108665.
Inkster T, Peters C, Dancer SJ. Safe design and maintenance of bone marrow transplant units: a narrative review. Clin Microbiol Infect. 2022.
Gadelkarim M, Elmegeed AAbd, Hafez A, Awad AK, Shehata MAhmed, AbouEl-Enein A, Alsadek MEid, Deeb MAbo, Afifi AM. Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Joint Bone Spine. 2022:105404.
Kim K-I, Lee W-S, Kim J-H, Bae J-K, Jin W. Safety and Efficacy of the Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritic Knee: A 5-Year Follow-up Study. Stem Cells Transl Med. 2022.
Saini R, Pahwa B, Agrawal D, Singh P, Gurjar H, Mishra S, Jagdevan A, Misra MChandra. Safety and feasibility of intramedullary injected bone marrow-derived mesenchymal stem cells in acute complete spinal cord injury: phase 1 trial. J Neurosurg Spine. 2022:1-8.
Sethi T, Montanari F, Foss F. Safety considerations with the current treatments for peripheral T-cell lymphoma. Expert Opin Drug Saf. 2022:1-8.
Burton KA, Mahen E, Konnick EQuentin, Blau S, Dorschner MO, Ramirez AB, Schmechel SC, Song C, Parulkar R, Parker S, et al. Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer. JCO Precis Oncol. 2022;6:e2100280.
Tiede A, Leise H, Horneff S, Oldenburg J, Halimeh S, Heller C, Königs C, Holstein K, Pfrepper C. Safety of intramuscular COVID-19 vaccination in patients with haemophilia. Haemophilia. 2022.
Shim S-H, Tufa D, Woods R, George TD, Shank T, Yingst A, Lake J, Cobb L, Jones D, Jones K, et al. SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium. Stem Cells Transl Med. 2022.
Li L, Hu G, Xie R, Yang J, Shi X, Jia Z, Qu X, Wang M, Wu Y. Salubrinal-mediated activation of eIF2α signaling improves oxidative stress-induced BMSCs senescence and senile osteoporosis. Biochem Biophys Res Commun. 2022;610:70-76.
Morgado-Palacin L. Sara Wickström: The forces controlling our cell fate. J Cell Biol. 2022;221(6).
Vavougios GD, Zarogiannis SG, Hadjigeorgiou G, Krogfelt KA, Gourgoulianis KI. SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe. Stem Cell Reports. 2022;17(5):1012-1013.
Vitale-Cross L, Szalayova I, Scoggins A, Palkovits M, Mezey E. SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications. EBioMedicine. 2022;78:103981.
Surendran H, Kumar S, Narasimhaiah S, Ananthamurthy A, Varghese PS, D'Souza GA, Medigeshi G, Pal R. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways. J Cell Physiol. 2022.
Menuchin-Lasowski Y, Schreiber A, Lecanda A, Mecate-Zambrano A, Brunotte L, Psathaki OE, Ludwig S, Rauen T, Schöler HR. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem Cell Reports. 2022.
Reiser J, Spear R, Luo S. SARS-CoV-2 pirates the kidneys: A scar(y) story. Cell Metab. 2022;34(3):352-354.
Muhl L, He L, Sun Y, Mäe MAndaloussi, Pietilä R, Liu J, Genové G, Zhang L, Xie Y, Leptidis S, et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Reports. 2022.
Hillier K, Rothman JA, Klaassen RJ, Neunert C, Rose MJ, Grace RF, Lambert MP. SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia. Pediatr Blood Cancer. 2022:e29760.
Piñana JLuis, López-Corral L, Martino R, Vázquez L, Pérez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, et al. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. J Hematol Oncol. 2022;15(1):54.
Guo J, Chen Z, Xiao Y, Yu G, Li Y. SATB1 promotes osteogenic differentiation of diabetic rat BMSCs through MAPK signalling activation. Oral Dis. 2022.
Kwok CKeong, Sébastien I, Hariharan K, Meiser I, Wihan J, Altmaier S, Karnatz I, Feile A, Cabrera-Socorro A, Rasmussen M, et al. Scalable expansion of iPSC and their derivatives across multiple lineages. Reprod Toxicol. 2022.
Liu Q, Luo X, Li J, Wang G. scESI: evolutionary sparse imputation for single-cell transcriptomes from nearest neighbor cells. Brief Bioinform. 2022.
Rubinstein JD, Lutzko C, Leemhuis T, Zhu X, Pham G, Ray LM, Thomas S, Dourson C, Wilhelm J, Lane A, et al. Scheduled Administration of Virus-Specific T cells for Viral Prophylaxis After Pediatric Allogeneic Stem Cell Transplant. Blood Adv. 2022.
Ding L, Shu Z, Hao J, Luo X, Ye X, Zhu W, Duan W, Chen Z. Schixator, a new FXa inhibitor from Schistosoma japonicum with antithrombotic effect and low bleeding risk. Biochem Biophys Res Commun. 2022;603:138-143.
Sahu RKrishna, Kumar B, Singh R, Kumari S, Tandon S, Das BChander, Hedau ST. Schleichera oleosa Seed Extract Reduced the Proliferation of Breast Cancer by Regulating the BRCA1 and p16 Genes. Asian Pac J Cancer Prev. 2022;23(1):151-160.

Pages